Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Nonalcoholic Steatohepatitis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableUnknownNCT06341790
What this trial is testing

Effect of Consumption of Millet Diet in Patients With NAFLD

Who this might be right for
NAFLD
Institute of Liver and Biliary Sciences, India 60
Not applicableStudy completedNCT07269197
What this trial is testing

Association of SGLT2 Inhibitors Therapy With Elastographic and Molecular Markers of Liver Injury in Type 2 Diabetes

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseDiabetes Mellitus, Type 2
Josip Juraj Strossmayer University of Osijek 67
Not applicableStudy completedNCT04161703
What this trial is testing

Effect of Focused Ultrasound on Abdominal and Intrahepatic Fat in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Fatty Liver
Cairo University 50
Not applicableLooking for participantsNCT05335603
What this trial is testing

An Observational Study Evaluating Patients With Chronic Liver Diseases Associated With Hepatic Steatosis

Who this might be right for
Chronic Liver Disease
University of Copenhagen 335
Not applicableStudy completedNCT03300661
What this trial is testing

Non Alcoholic Fatty Liver Disease: Nutritional Epidemiology and Lifestyle Medicine

Who this might be right for
Non Alcoholic Fatty Liver DiseaseLifestyleDiet Modification
Università degli Studi di Brescia 100
Post-approval studies (Phase 4)Looking for participantsNCT06989723
What this trial is testing

Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes

Who this might be right for
Type 2 DiabetesFatty Liver
Seoul National University Bundang Hospital 120
Large-scale testing (Phase 3)Looking for participantsNCT06461208
What this trial is testing

A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis

Who this might be right for
Liver Cirrhosis
King's College London 300
Not applicableUnknownNCT05855239
What this trial is testing

Quantification of Hepatic Steatosis With Different Ultrasound Frequency

Who this might be right for
Fatty LiverFatty Liver, NonalcoholicUltrasound
Jong Keon Jang 120
Post-approval studies (Phase 4)Study completedNCT03646292
What this trial is testing

Antidiabetic Drugs for Steatotic Liver Disease

Who this might be right for
MASLD - Metabolic Dysfunction-Associated Steatotic Liver DiseaseType 2 DiabetesDigestive System Disease+11 more
Yonsei University 51
Not applicableStudy completedNCT02728765
What this trial is testing

Obstructive Sleep Apnoea and CPAP Treatment Response in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Obstructive Sleep ApneaNon-alcoholic Fatty Liver Disease
Chinese University of Hong Kong 120
Testing effectiveness (Phase 2)Study completedNCT04052516
What this trial is testing

A Phase 2b Study of Icosabutate in Fatty Liver Disease

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
NorthSea Therapeutics B.V. 280
Not applicableStudy completedNCT06275906
What this trial is testing

Influence of a Mediterranean Diet Combined With a Physical Activity Intervention, on NAFLD and Inflammation Parameters.

Who this might be right for
NAFLDObesityIBS
Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis 36
Not applicableStudy completedNCT07730736
What this trial is testing

Analysis of Clinical Characteristics of Chronic Hepatitis B Combined With MAFLD in Different TCM Syndrome Types

Who this might be right for
Chronic Hepatitis BMetabolic Associated Fatty Liver Disease
Foshan Hospital of Traditional Chinese Medicine 1,000
Not applicableEnded earlyNCT00375011
What this trial is testing

Breath Test to Assess Hepatic Metabolic Reserve and to Predict Hepatic Decompensation in Cirrhotics

Who this might be right for
Cirrhosis
Meridian Bioscience, Inc. 200
Testing effectiveness (Phase 2)Study completedNCT02546609
What this trial is testing

The Effect Of NS-0200 Versus Placebo On Hepatic Fat Content In Patients With Non Alcoholic Fatty Liver Disease

Who this might be right for
NAFLD
NuSirt Biopharma 91
Not applicableStudy completedNCT05370053
What this trial is testing

The Availability of the Enhanced Liver Fibrosis (ELF) Test Affects the Rate of Diagnosis of Nonalcoholic Steatohepatitis (NASH) With Fibrosis in Patients Referred to Hepatology

Who this might be right for
Fatty LiverNAFLD
University of Kansas Medical Center 450
Not applicableWithdrawnNCT02194894
What this trial is testing

The Effect of Acetaminophen on Non-alcoholic Fatty Liver Disease Patients

Who this might be right for
Non-alcoholic Fatty Liver Disease (NAFLD)
University of Southern California
Testing effectiveness (Phase 2)Ended earlyNCT04065841
What this trial is testing

Efficacy, Safety and Tolerability of the Combination of Tropifexor & Licogliflozin and Each Monotherapy, Compared With Placebo in Adult Patients With NASH and Liver Fibrosis.

Who this might be right for
Non Alcoholic Steatohepatitis (NASH)
Novartis Pharmaceuticals 234
Not applicableWithdrawnNCT05130346
What this trial is testing

Effects of Mindfulness Based Stress Reduction Intervention in Patients With Non-alcoholic Fatty Liver Disease

Who this might be right for
Non-Alcoholic Fatty Liver DiseaseFatty Liver, NonalcoholicObesity
Virginia Commonwealth University
Not applicableStudy completedNCT06338618
What this trial is testing

Manual Therapy in Metabolic Liver Disease

Who this might be right for
NAFLD, Non-alcoholic Fatty Liver Disease
University of Seville 42
Next Page